Outcomes In Patients With Hematologic Disease And Covid-19 In Russia: Interim Analysis Of Chronos19 Registry

BLOOD(2020)

Cited 7|Views5
No score
Abstract
Background: Patients (pts) with hematologic disease are at increased risk of severe SARS-CoV-2 infection. Recent observations reported poor outcomes of COVID-19 in pts with various cancer types and higher mortality rates compared with the general population. However, currently available data on COVID-19 in pts with hematologic disease are limited.
More
Translated text
Key words
hematologic disease,chronos19 registry,patients
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined